Correlation Between Acumen Pharmaceuticals and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Inhibrx, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Inhibrx.
Diversification Opportunities for Acumen Pharmaceuticals and Inhibrx
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Acumen and Inhibrx is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Inhibrx go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Inhibrx
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Inhibrx. In addition to that, Acumen Pharmaceuticals is 1.26 times more volatile than Inhibrx. It trades about -0.01 of its total potential returns per unit of risk. Inhibrx is currently generating about 0.0 per unit of volatility. If you would invest 2,526 in Inhibrx on August 27, 2024 and sell it today you would lose (1,040) from holding Inhibrx or give up 41.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Inhibrx
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Inhibrx |
Acumen Pharmaceuticals and Inhibrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Inhibrx
The main advantage of trading using opposite Acumen Pharmaceuticals and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |